(Q34436230)

2 August 2017

title

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial (English)

1 reference

adaptive radiation therapy

2 August 2017

main subject

0 references

1 reference

R T D Oliver

1

1 reference

2 August 2017

M D Mason

2

1 reference

2 August 2017

G M Mead

3

1 reference

2 August 2017

H von der Maase

4

1 reference

2 August 2017

G J S Rustin

5

1 reference

2 August 2017

J K Joffe

6

1 reference

2 August 2017

R de Wit

7

1 reference

2 August 2017

N Aass

8

1 reference

2 August 2017

J D Graham

9

1 reference

2 August 2017

R Coleman

10

1 reference

2 August 2017

S J Kirk

11

1 reference

2 August 2017

S P Stenning

12

1 reference

2 August 2017

MRC TE19 collaborators and the EORTC 30982 collaborators

13

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

2 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

The Lancet

1 reference

2 August 2017

volume

366

1 reference

2 August 2017

issue

9482

1 reference

2 August 2017

page(s)

293-300

1 reference

Mortality after cure of testicular seminoma.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Limitations to the use of surveillance as an option in the management of stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Second tumors after radiation treatment of testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Possible new approaches to the management of seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Alternatives to radiotherapy in the management of seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Metastatic germ cell tumors: modeling for response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Reciprocal translocations in patients with testicular seminoma before and after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Effect of chemotherapy on carcinoma in situ of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966984-X

7 January 2021

10.1016/S0140-6736(05)66984-X

Identifiers

DOI

1 reference

release_2b3hy2zitjbf3oa4xa5s6zs6hq

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2b3hy2zitjbf3oa4xa5s6zs6hq

24 November 2022

mapped directly with Wikidata item

1 reference